Vascular endothelial growth factor response to exogenous chorionic gonadotropic hormone in the luteal phase of women with a history of severe ovarian hyperstimulation syndrome.
Ovarian hyperstimulation syndrome (OHSS) is a severe complication of ovarian stimulation. No reliable test exists to predict the syndrome. The objective of the present prospective observational study was to examine vascular endothelial growth factor (VEGF) secretion after human chorionic gonadotropin (hCG) administration in the luteal phase of a spontaneous cycle of women with a history of severe OHSS. Five women with a history of severe OHSS were administered 250 mug recombinant hCG intravenously on day 21 of a spontaneous menstrual cycle. Plasma samples were collected at regular intervals from 15 min before hCG to 6 h thereafter and the free VEGF plasma concentrations were determined. Plasma levels of free VEGF remained at the lower detection limit of the assay throughout the observational period. Women with previous severe OHSS do not show a significant short-time response of VEGF secretion upon hCG administration. No evidence was found to support the notion that women inclined to develop a severe form of the syndrome after ovarian stimulation could possibly be identified by the VEGF short-time secretory response to exogenous hCG in the luteal phase of a spontaneous cycle.
Griesinger
Georg
G
Department of Obstetrics and Gynecology, Universitaetsklinikum Schleswig-Holstein, Campus Luebeck, Ratzeburger Allee 160, 23538, Luebeck, Luebeck. georg.griesinger@frauenklinik.uni-luebeck.de
Dafopoulos
Konstantinos
K
Schultze-Mosgau
Askan
A
Jelkmann
Wolfgang
W
von Otte
Soeren
S
Diesing
Dagmar
D
Diedrich
Klaus
K
D000328:Adult; D015415:Biomarkers; D006063:Chorionic Gonadotropin / Q000494:pharmacology*; D005260:Female; D006801:Humans; D008183:Luteal Phase; D016471:Ovarian Hyperstimulation Syndrome / Q000503:physiopathology*; D012102:Reproductive Control Agents / Q000494:pharmacology*; D027724:Reproductive Techniques, Assisted / Q000009:adverse effects; D042461:Vascular Endothelial Growth Factor A / Q000097:blood / Q000378:metabolism*
D015415:Biomarkers; D006063:Chorionic Gonadotropin; D012102:Reproductive Control Agents; D042461:Vascular Endothelial Growth Factor A